ASX:4DXHealthcare Services
Assessing 4DMedical (ASX:4DX) Valuation After Expanded Philips CT:VQ Distribution Deal
4DMedical (ASX:4DX) just announced a significant expansion of its distribution agreement with Koninklijke Philips for its FDA cleared CT:VQ non contrast lung imaging solution, sharpening investor focus on how widely this technology could scale.
See our latest analysis for 4DMedical.
The expanded Philips deal lands on top of a sharp run, with 4DMedical delivering a 51.02% 1 month share price return and a 377.42% 1 year total shareholder return. This suggests momentum is still building despite...